• Donate now
  • Monthly Giving
  • Support Calendar – What’s On
  • Contact us
  • About us
    • Our vision
    • What we do
    • Our Impact
    • Our team
    • Work for us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Celebrating our Action Duchenne Champions
  • Get Support
    • Recently diagnosed
    • Group Counselling Programme
    • Connect with others
      • Online support sessions
      • Support for 14-25 yrs ‘Yes I Can’
      • Support for 8-14 yrs ‘Turning Point’
    • Science on Tour 2023
    • Schools
    • Siblings
    • End of Life & Bereavement
  • International Conference
    • 2022 Recordings
  • News, Blogs & Webinars
    • News
    • Blogs
    • Webinar recordings
  • Challenge 79
  • Support Us
    • Make a Pledge
  • Shop
  •  0 items - Free
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • BECOME A MEMBER
  • SHOP
  • My account
  •  0 items - Free

Action Duchenne

Header Right

  • About Us
    • Our vision
    • Our Strategy
    • What we do
    • Our Impact
    • Our team
    • Work for us
      • Volunteer for us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Mental Health Awareness Week 2025
    • Science on Tour
    • Support Calendar – What’s On
    • Support for you and your family
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
      • Open Space
      • Group Counselling Programme
    • Recently diagnosed
    • Connect with others
    • Support for 8-14 yrs ‘Turning Point’
    • Support for 14-25 yrs ‘Yes I Can’
    • Schools
    • Siblings
    • End of Life and Bereavement
  • AD Annual International Conference
    • SAVE THE DATE for the Action Duchenne Annual International Conference 2025
    • Highlights from the Annual Action Duchenne Annual International 2024
    • Annual International Conference 2023 Video Recordings
    • Annual International Conference 2022 Recordings
      • Adults with Duchenne
      • Growing up with Duchenne
      • The Duchenne Journey
      • What is new in Duchenne research?
  • News, Webinars and Blogs
    • News
    • Webinar Series 2025
      • Webinar Series 2025
      • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Blogs
  • Support Us
    • Help Make a Life Beyond Duchenne Possible – Every Month
    • Fundraising Events and Challenges
    • Take on a challenge for Duchenne
    • Shop

News

You are here: Home / News

Dyne Therapeutics Announce New Long Terms Clinical Data from DELIVER Trial of DYNE 251

March 26, 2025 by John Marrin

Dyne Therapeutics recently announced new long-term clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 demonstrating sustained …

Dyne Therapeutics Announce New Long Terms Clinical Data from DELIVER Trial of DYNE 251Read More

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201

March 24, 2025 by Mehreen Arif

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of …

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201Read More

Capricor Therapeutics Reports Positive Long-Term Results for Deramiocel in Treating Duchenne Muscular Dystrophy

March 20, 2025 by John Marrin

This week Capricor Therapeutics announced positive long-term data from its' ongoing HOPE-2 open-label extension (OLE) clinical trial, highlighting the …

Capricor Therapeutics Reports Positive Long-Term Results for Deramiocel in Treating Duchenne Muscular DystrophyRead More

Action Duchenne’s Statement Regarding Sarepta’s Sad Announcement

March 19, 2025 by John Marrin

We are deeply saddened to learn of the passing of a young man who received ELEVIDYS gene therapy for Duchenne muscular dystrophy. Our hearts go out to …

Action Duchenne’s Statement Regarding Sarepta’s Sad AnnouncementRead More

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD

March 12, 2025 by John Marrin

PepGen's has released an update regarding the CONNECT clinical trials for PGN-EDO51 in Duchenne muscular dystrophy (DMD). PepGen has announced a …

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMDRead More

Roche Shares Top-line Results from Year Two of the EMBARK Phase 3 Clinical Trial.

March 12, 2025 by John Marrin

Roche have provided an update on the latest top-line results from the second year of their EMBARK Phase 3 clinical trial (NCT05096221) investigating …

Roche Shares Top-line Results from Year Two of the EMBARK Phase 3 Clinical Trial.Read More

Calling all Siblings and Caregivers of Individuals with Duchenne

March 5, 2025 by John Marrin

Help researchers and mental health professionals at the University of Newcastle better understand how Duchenne muscular dystrophy (DMD) impacts …

Calling all Siblings and Caregivers of Individuals with DuchenneRead More

Vamorolone for Duchenne Muscular Dystrophy: A Summary of Evidence So Far

March 5, 2025 by John Marrin

DMD Care UK will host a webinar to summarise the evidence for vamorolone as a treatment for Duchenne muscular dystrophy (DMD), and provide an …

Vamorolone for Duchenne Muscular Dystrophy: A Summary of Evidence So FarRead More

Open Letter from the Chair and CEO of Action Duchenne for Rare Disease Day 2025

February 28, 2025 by Lizzie Deeble

Dear Friends, Supporters, and Advocates, On Rare Disease Day 2025, we stand together to raise awareness, celebrate our community, and drive …

Open Letter from the Chair and CEO of Action Duchenne for Rare Disease Day 2025Read More

Solid Biosciences Shares 90 Day Update From SGT-003 Gene Therapy Trial

February 26, 2025 by John Marrin

We're excited to share news that Solid Biosciences has released initial data from its Phase 1/2 INSPIRE DUCHENNE clinical trial, assessing the safety …

Solid Biosciences Shares 90 Day Update From SGT-003 Gene Therapy TrialRead More

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

February 25, 2025 by Lizzie Deeble

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44 Entrada Therapeutics, today announced that the United States Food and …

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44Read More

Family Science Education Day and Charity Dinner Dance

February 14, 2025 by Lizzie Deeble

Family Science Education Day and Charity Dinner Dance Join us for a Family Day at Birmingham's Think Tank Science Museum followed by a Charity …

Family Science Education Day and Charity Dinner DanceRead More

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 46
  • Go to Next Page »

Footer

Action Duchenne
Wellesley House
Duke of Wellington Avenue Royal Arsenal
London
SE18 6SS

07535 498 506
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852

Like most websites we use cookies to deliver a personalised service. To use the website as intended please accept cookies.
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT